Cargando…

西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980642/
https://www.ncbi.nlm.nih.gov/pubmed/35381682
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.02.016
_version_ 1784681436740059136
collection PubMed
description
format Online
Article
Text
id pubmed-8980642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-89806422022-04-13 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2022-02 /pmc/articles/PMC8980642/ /pubmed/35381682 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.02.016 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 病例报告
西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title_full 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title_fullStr 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title_full_unstemmed 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title_short 西达本胺联合PD-1单抗治疗Sézary综合征获得持续缓解1例
title_sort 西达本胺联合pd-1单抗治疗sézary综合征获得持续缓解1例
topic 病例报告
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980642/
https://www.ncbi.nlm.nih.gov/pubmed/35381682
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.02.016
work_keys_str_mv AT xīdáběnànliánhépd1dānkàngzhìliáosezaryzōnghézhēnghuòdéchíxùhuǎnjiě1lì
AT xīdáběnànliánhépd1dānkàngzhìliáosezaryzōnghézhēnghuòdéchíxùhuǎnjiě1lì
AT xīdáběnànliánhépd1dānkàngzhìliáosezaryzōnghézhēnghuòdéchíxùhuǎnjiě1lì
AT xīdáběnànliánhépd1dānkàngzhìliáosezaryzōnghézhēnghuòdéchíxùhuǎnjiě1lì